RightEye, LLC

RightEye operates at the intersection of digital health, diagnostic medical devices, vision therapy, sports technology, and computer vision. Its differentiation is the conversion of eye movement into measurable clinical and performance data rather than relying solely on conventional static visual-acuity testing. The portfolio spans the RightEye Sensorimotor System, RightEye Vision System, Dynamic Vision Trainer, Reading Skills Assessment, and eye-tracking data licensing. The company also combines research-grade VisionTracker2 hardware with cloud-based analysis, automated assessments, and specialized modules for sensorimotor testing, sports vision, reading, and dynamic vision. This creates a broader use-case footprint than a single-purpose ophthalmic diagnostic, but it also exposes RightEye to varying evidence, reimbursement, and regulatory requirements across healthcare, education, wellness, and athletics. RightEye’s competitive position is therefore best characterized by its specialized eye-movement dataset, patented cloud platform, integrated hardware-software workflow, and clinical orientation. Its FDA-related scrutiny in 2023 remains an important consideration when assessing commercialization and market access.

RightEye’s growth trajectory shows a long development cycle followed by expansion into multiple application areas. The company was founded in 2012, with Adam Gross and Dr. Melissa Hunfalvay identified as co-founders. It raised $450,000 in a seed round on May 3, 2013, followed by a $1 million angel round in 2014, a $2.105 million convertible note in 2016, a $7.3 million venture round in 2017, a $1.5 million venture round in 2018, and $1 million in debt financing on Mar 2, 2020. The six rounds total $13.355 million. Product development progressed from portable eye tracking and research-oriented measurement toward named systems, cloud analytics, clinical assessments, training programs, and data licensing. Commercial signals include the 2019 USA Baseball sports-vision collaboration and the 2023 introduction of the EyeQ Vision Test by Family Eyecare Solutions. Current employee data indicates a company size band of 11-50 people, while only two current positions are specifically identified.